A narrative review of the role of gastrointestinal dysbiosis in the pathogenesis of polycystic ovary syndrome

키워드

참고문헌 (113)

1. Ding T, "The prevalence of polycystic ovary syndrome in reproductive-aged women of different ethnicity : a systematic review and meta-analysis", Oncotarget, 8, pp.96351~96358 (2017)
2. Boyle JA, "Prevalence of polycystic ovary syndrome in a sample of Indigenous women in Darwin, Australia", Med J Aust, 196, pp.62~66 (2012)
3. Pathak G, "Polycystic ovary syndrome in globalizing India : an ecosocial perspective on an emerging lifestyle disease", Soc Sci Med, 146, pp.21~28 (2015)
4. "Proportion of selected age groups of world population in 2021, by region" (2021)[URL]
5. Parker J, "Understanding the pathogenesis of polycystic ovary syndrome : a transgenerational evolutionary adaptation to lifestyle and the environment", J ACNEM, 39, pp.18~26 (2020)
6. Charifson MA, "Evolutionary origins of polycystic ovary syndrome : an environmental mismatch disorder", Evol Med Public Health, 2019, pp.50~63 (2019)
7. Azziz R, "Polycystic ovary syndrome : an ancient disorder?", Fertil Steril, 95, pp.1544~1548 (2011)
8. "International evidence-based guideline for the assessment and management of polycystic ovary syndrome 2018" (2018)[URL]
9. Benton ML, "The influence of evolutionary history on human health and disease", Nat Rev Genet, 22, pp.269~283 (2021)
10. Tremellen K, "Dysbiosis of gut microbiota(DOGMA)--a novel theory for the development of polycystic ovarian syndrome", Med Hypotheses, 79, pp.104~112 (2012)
11. Nuriel-Ohayon M, "Microbial changes during pregnancy, birth, and infancy", Front Microbiol, 7, pp.1031~ (2016)
12. Yurtdaş G, "A new approach to polycystic ovary syndrome : the gut microbiota", J Am Coll Nutr, 39, pp.371~382 (2020)
13. Zhao X, "Exploration of the relationship between gut microbiota and polycystic ovary syndrome(PCOS) : a review", Geburtshilfe Frauenheilkd, 80, pp.161~171 (2020)
14. He FF, "Role of gut microbiota in the development of insulin resistance and the mechanism underlying polycystic ovary syndrome : a review", J Ovarian Res, 13, pp.73~ (2020)
15. Yatsunenko T, "Human gut microbiome viewed across age and geography", Nature, 486, pp.222~227 (2012)
16. Human Microbiome Project Consortium, "Structure, function and diversity of the healthy human microbiome", Nature, 486, pp.207~214 (2012)
17. Tuddenham S, "The intestinal microbiome and health", Curr Opin Infect Dis, 28, pp.464~ (2015)
18. García-Montero C, "Nutritional components in western diet versus mediterranean diet at the gut microbiota-immune system interplay. Implications for health and disease", Nutrients, 13, pp.699~ (2021)
19. David LA, "Diet rapidly and reproducibly alters the human gut microbiome", Nature, 505, pp.559~563 (2014)
20. Perez NB, "Dysbiosis of the gut microbiome : a concept analysis", J Holist Nurs, 38, pp.223~232 (2020)
21. Alexander R. Moschen, "Dietary Factors: Major Regulators of the Gut’s Microbiota", Gut and Liver, 6(4), pp.411~416 (2012), 거트앤리버 소화기연관학회협의회
22. Hawrelak JA, "The causes of intestinal dysbiosis : a review", Altern Med Rev, 9, pp.180~197 (2004)
23. Vujkovic-Cvijin I, "Host variables confound gut microbiota studies of human disease", Nature, 587, pp.448~454 (2020)
24. Moya A, "Functional redundancy-induced stability of gut microbiota subjected to disturbance", Trends Microbiol, 24, pp.402~413 (2016)
25. Partula V, "Associations between usual diet and gut microbiota composition : results from the Milieu Intérieur cross-sectional study", Am J Clin Nutr, 109, pp.1472~1483 (2019)
26. Manichanh C, "Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach", Gut, 55, pp.205~211 (2006)
27. O’Brien CL, "Detection of bacterial DNA in lymph nodes of Crohn’s disease patients using high throughput sequencing", Gut, 63, pp.1596~1606 (2014)
28. Wang T, "Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers", ISME J, 6, pp.320~329 (2012)
29. Mammadova G, "Characterization of gut microbiota in polycystic ovary syndrome : findings from a lean population", Eur J Clin Invest, 51, pp.e13417~ (2021)
30. Haudum C, "Impact of short-term isoflavone intervention in polycystic ovary syndrome(PCOS)patients on microbiota composition and metagenomics", Nutrients, 12, pp.1622~ (2020)
31. Zhang J, "Probiotic bifidobacterium lactis V9 regulates the secretion of sex hormones in polycystic ovary syndrome patients through the gut-brain axis", mSystems, 4, pp.e00017~e00119 (2019)
32. Insenser M, "Gut microbiota and the polycystic ovary syndrome : influence of sex, sex hormones, and obesity", J Clin Endocrinol Metab, 103, pp.2552~2562 (2018)
33. Eyupoglu ND, "Gut Microbiota and oral contraceptive use in overweight and obese patients with polycystic ovary syndrome", J Clin Endocrinol Metab, 105, pp.dgaa600~ (2020)
34. Qi X, "Gut microbiota-bile acid-interleukin-22 axis orchestrates polycystic ovary syndrome", Nat Med, 25, pp.1225~1233 (2019)
35. Jobira B, "Obese adolescents with PCOS have altered biodiversity and relative abundance in gastrointestinal microbiota", J Clin Endocrinol Metab, 105, pp.e2134~e2144 (2020)
36. Lindheim L, "Alterations in gut microbiome composition and barrier function are associated with reproductive and metabolic defects in women with polycystic ovary syndrome(PCOS) : a pilot study", PLoS One, 12, pp.e0168390~ (2017)
37. Liu R, "Dysbiosis of gut microbiota associated with clinical parameters in polycystic ovary syndrome", Front Microbiol, 8, pp.324~ (2017)
38. Torres PJ, "Gut microbial diversity in women with polycystic ovary syndrome correlates with hyperandrogenism", J Clin Endocrinol Metab, 103, pp.1502~1511 (2018)
39. Chen F, "Analysis of the gut microbial composition in polycystic ovary syndrome with acne", Zigong Matern Child Heal Hosp, 35, pp.2246~2251 (2019)
40. Zhou L, "Characteristic gut microbiota and predicted metabolic functions in women with PCOS", Endocr Connect, 9, pp.63~73 (2020)
41. Garcia-Beltran C, "Gut microbiota in adolescent girls with polycystic ovary syndrome : effects of randomized treatments", Pediatr Obes, 16, pp.e12734~ (2021)
42. Zeng B, "Structural and functional profiles of the gut microbial community in polycystic ovary syndrome with insulin resistance(IR-PCOS) : a pilot study", Res Microbiol, 170, pp.43~52 (2019)
43. Rizk MG, "Intersection of polycystic ovary syndrome and the gut microbiome", J Endocr Soc, 5, pp.bvaa177~ (2020)
44. Lim SS, "Lifestyle changes in women with polycystic ovary syndrome", Cochrane Database Syst Rev, 3, pp.CD007506~ (2019)
45. González F, "Saturated fat ingestion promotes lipopolysaccharidemediated inflammation and insulin resistance in polycystic ovary syndrome", J Clin Endocrinol Metab, 104, pp.934~946 (2019)
46. Zhu Q, "Serum LBP Is associated with insulin resistance in women with PCOS", PLoS One, 11, pp.e0145337~ (2016)
47. Gutsmann T, "Dual role of lipopolysaccharide(LPS)-binding protein in neutralization of LPS and enhancement of LPS-induced activation of mononuclear cells", Infect Immun, 69, pp.6942~6950 (2001)
48. Zhang D, "Serum zonulin is elevated in women with polycystic ovary syndrome and correlates with insulin resistance and severity of anovulation", Eur J Endocrinol, 172, pp.29~36 (2015)
49. Anik Ilhan G, "Evaluation of zonulin, a marker of intestinal permeability as a novel biomarker in polycystic ovary syndrome", Fertil Steril, 110, pp.e117~ (2018)
50. Banaszewska B, "Elevation of markers of endotoxemia in women with polycystic ovary syndrome", Hum Reprod, 35, pp.2303~2311 (2020)
51. Fasano A, "The enterotoxic effect of zonula occludens toxin on rabbit small intestine involves the paracellular pathway", Gastroenterology, 112, pp.839~846 (1997)
52. Larkin M, "Out with the jab, in with the painless pills", Lancet, 349, pp.1676~ (1997)
53. Fasano A, "Zonulin and its regulation of intestinal barrier function : the biological door to inflammation, autoimmunity, and cancer", Physiol Rev, 91, pp.151~175 (2011)
54. Fasano A, "Intestinal permeability and its regulation by zonulin : diagnostic and therapeutic implications", Clin Gastroenterol Hepatol, 10, pp.1096~1100 (2012)
55. Sapone A, "Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives", Diabetes, 55, pp.1443~1449 (2006)
56. Fasano A, "Zonulin, regulation of tight junctions, and autoimmune diseases", Ann N Y Acad Sci, 1258, pp.25~33 (2012)
57. Kim AS, "Plasma concentrations of zonulin are elevated in obese men with fatty liver disease", Diabetes Metab Syndr Obes, 11, pp.149~157 (2018)
58. Aasbrenn M, "Changes in serum zonulin in individuals with morbid obesity after weight-loss interventions : a prospective cohort study", BMC Endocr Disord, 20, pp.108~ (2020)
59. Yuan JH, "Impaired intestinal barrier function in type 2diabetic patients measured by serum LPS, zonulin, and IFABP", J Diabetes Complications, 35, pp.107766~ (2021)
60. Lingaiah S, "Markers of gastrointestinal permeability and dysbiosis in premenopausal women with PCOS : a case-control study", BMJ Open, 11, pp.e045324~ (2021)
61. Cetin Z, "Serum zonulin level is not elevated in patients with polycystic ovary syndrome without metabolic syndrome", Arch Gynecol Obstet, 300, pp.1785~1790 (2019)
62. Ajamian M, "Serum zonulin as a marker of intestinal mucosal barrier function : may not be what it seems", PLoS One, 14, pp.e0210728~ (2019)
63. "Widely used commercial ELISA for human Zonulin reacts with Complement C3 rather than pre-Haptoglobin 2" (2017)[URL]
64. Scheffler L, "Widely used commercial elisa does not detect precursor of haptoglobin2, but recognizes properdin as a potential second member of the zonulin family", Front Endocrinol(Lausanne), 9, pp.22~ (2018)
65. Sina C, "The intestinal complement system in inflammatory bowel disease : shaping intestinal barrier function", Semin Immunol, 37, pp.66~73 (2018)
66. Sünderhauf A, "Regulation of epithelial cell expressed C3 in the intestine-relevance for the pathophysiology of inflammatory bowel disease?", Mol Immunol, 90, pp.227~238 (2017)
67. Liao D, "Meta-analysis of the effects of probiotic supplementation on glycemia, lipidic profiles, weight loss and C-reactive protein in women with polycystic ovarian syndrome", Minerva Med, 109, pp.479~487 (2018)
68. Heshmati J, "The effects of probiotics or synbiotics supplementation in women with polycystic ovarian syndrome : a systematic review and meta-analysis of randomized clinical trials", Probiotics Antimicrob Proteins, 11, pp.1236~1247 (2019)
69. Hadi A, "Effect of probiotics and synbiotics on selected anthropometric and biochemical measures in women with polycystic ovary syndrome : a systematic review and meta-analysis", Eur J Clin Nutr, 74, pp.543~547 (2020)
70. Shamasbi SG, "The effect of probiotics, prebiotics, and synbiotics on hormonal and inflammatory indices in women with polycystic ovary syndrome : a systematic review and meta-analysis", Eur J Nutr, 59, pp.433~450 (2020)
71. Tabrizi R, "The effects of probiotic supplementation on clinical symptom, weight loss, glycemic control, lipid and hormonal profiles, biomarkers of inflammation, and oxidative stress in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials", Probiotics Antimicrob Proteins (2019)[DOI]
72. Kazemi A, "Effect of probiotic and synbiotic supplementation on inflammatory markers in health and disease status : a systematic review and meta-analysis of clinical trials", Clin Nutr, 39, pp.789~819 (2020)
73. Cozzolino M, "Therapy with probiotics and synbiotics for polycystic ovarian syndrome : a systematic review and meta-analysis", Eur J Nutr, 59, pp.2841~2856 (2020)
74. Miao C, "Effects of probiotic and synbiotic supplementation on insulin resistance in women with polycystic ovary syndrome : a meta-analysis", J Int Med Res, 49, pp.3000605211031758~ (2021)
75. Li Y, "Effects of probiotics, prebiotics, and synbiotics on polycystic ovary syndrome : a systematic review and meta-analysis", Crit Rev Food Sci Nutr (2021)[DOI]
76. Gibson GR, "Expert consensus document : the international scientific association for probiotics and prebiotics(ISAPP)consensus statement on the definition and scope of prebiotics", Nat Rev Gastroenterol Hepatol, 14, pp.491~502 (2017)
77. Hawrelak J., "Textbook of natural medicine", pp.797~808 (2020), Elsevier
78. Gibson GR, "Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin", Gastroenterology, 108, pp.975~982 (1995)
79. Ballongue J, "Effects of lactulose and lactitol on colonic microflora and enzymatic activity", Scand J Gastroenterol Suppl, 222, pp.41~44 (1997)
80. Vulevic J, "Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture(B-GOS)in healthy elderly volunteers", Am J Clin Nutr, 88, pp.1438~1446 (2008)
81. Dehghan P, "Inulin controls inflammation and metabolic endotoxemia in women with type 2 diabetes mellitus : a randomized-controlled clinical trial", Int J Food Sci Nutr, 65, pp.117~123 (2014)
82. Wang L, "Inulin-type fructans supplementation improves glycemic control for the prediabetes and type 2 diabetes populations : results from a GRADE-assessed systematic review and dose-response meta-analysis of 33 randomized controlled trials", J Transl Med, 17, pp.410~ (2019)
83. Vulevic J, "A mixture of trans-galactooligosaccharides reduces markers of metabolic syndrome and modulates the fecal microbiota and immune function of overweight adults", J Nutr, 143, pp.324~331 (2013)
84. Pain JA, "Experimental and clinical study of lactulose in obstructive jaundice", Br J Surg, 73, pp.775~778 (1986)
85. Jain L, "Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy", J Gastroenterol Hepatol, 28, pp.1187~1193 (2013)
86. Bianchi G, "Effect of lactulose on carbohydrate metabolism and diabetes mellitus", Scand J Gastroenterol Suppl, 222, pp.62~64 (1997)
87. SofiSA, "Resistant starch as functional ingredient : a review", Int J Food Sci Nutr, 2, pp.195~199 (2017)
88. Venkataraman A, "Variable responses of human microbiomes to dietary supplementation with resistant starch", Microbiome, 4, pp.33~ (2016)
89. Bendiks ZA, "Conserved and variable responses of the gut microbiome to resistant starch type 2", Nutr Res, 77, pp.12~28 (2020)
90. Halajzadeh J, "Effects of resistant starch on glycemic control, serum lipoproteins and systemic inflammation in patients with metabolic syndrome and related disorders : a systematic review and metaanalysis of randomized controlled clinical trials", Crit Rev Food Sci Nutr, 60, pp.3172~3184 (2020)
91. Gholizadeh Shamasbi S, "The effect of resistant dextrin as a prebiotic on metabolic parameters and androgen level in women with polycystic ovarian syndrome : a randomized, tripleblind, controlled, clinical trial", Eur J Nutr, 58, pp.629~640 (2019)
92. Shamasbi SG, "Effect of prebiotic on anthropometric indices in women with polycystic ovarian syndrome : a triple-blind, randomized, controlled clinical trial", Iran Red Crescent Med J, 20, pp.e67270~ (2018)
93. Hill C, "Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic", Nat Rev Gastroenterol Hepatol, 11, pp.506~514 (2014)
94. Perraudeau F, "Improvements to postprandial glucose control in subjects with type 2 diabetes : a multicenter, double blind, randomized placebo-controlled trial of a novel probiotic formulation", BMJ Open Diabetes Res Care, 8, pp.e001319~ (2020)
95. Mishra V, "Probiotics as potential antioxidants : a systematic review", J Agric Food Chem, 63, pp.3615~3626 (2015)
96. Imaoka A, "Anti-inflammatory activity of probiotic Bifidobacterium : enhancement of IL-10 production in peripheral blood mononuclear cells from ulcerative colitis patients and inhibition of IL-8 secretion in HT-29cells", World J Gastroenterol, 14, pp.2511~2516 (2008)
97. Guillot CC, "Effects of Saccharomyces boulardii in children with chronic diarrhoea, especially cases due to giardiasis", Rev Mex De Puericultura Y Pediatria, 2, pp.15~ (1995)
98. In Kim H, "Lactobacillus plantarum LC27 and Bifidobacterium longum LC67 simultaneously alleviate high-fat diet-induced colitis, endotoxemia, liver steatosis, and obesity in mice", Nutr Res, 67, pp.78~89 (2019)
99. Kocsis T, "Probiotics have beneficial metabolic effects in patients with type 2 diabetes mellitus : a meta-analysis of randomized clinical trials", Sci Rep, 10, pp.11787~ (2020)
100. del Campo R, "Improvement of digestive health and reduction in proteobacterial populations in the gut microbiota of cystic fibrosis patients using a Lactobacillus reuteri probiotic preparation : a double blind prospective study", J Cyst Fibros, 13, pp.716~722 (2014)
101. Odamaki T, "Effect of the oral intake of yogurt containing Bifidobacterium longum BB536 on the cell numbers of enterotoxigenic Bacteroides fragilis in microbiota", Anaerobe, 18, pp.14~18 (2012)
102. "Evidence of probiotic strain specificity makes extrapolation of results impossible from a strain to another, even from the same species" (2011)[URL]
103. Swanson KS, "The International scientific association for probiotics and prebiotics(ISAPP)consensus statement on the definition and scope of synbiotics", Nat Rev Gastroenterol Hepatol, 17, pp.687~701 (2020)
104. Hadi A, "Efficacy of synbiotic supplementation in obesity treatment : a systematic review and meta-analysis of clinical trials", Crit Rev Food Sci Nutr, 60, pp.584~596 (2020)
105. Ahmadi S, "The effects of synbiotic supplementation on markers of insulin metabolism and lipid profiles in gestational diabetes : a randomised, double-blind, placebo-controlled trial", Br J Nutr, 116, pp.1394~1401 (2016)
106. Zare Javid A, "The effects of synbiotic supplementation on glycemic status, lipid profile, and biomarkers of oxidative stress in type 1 diabetic patients. A placebocontrolled, double-blind, randomized clinical trial", Diabetes Metab Syndr Obes, 13, pp.607~617 (2020)
107. Tajabadi-Ebrahimi M, "A randomized controlled clinical trial investigating the effect of synbiotic administration on markers of insulin metabolism and lipid profiles in overweight type 2 diabetic patients with coronary heart disease", Exp Clin Endocrinol Diabetes, 125, pp.21~27 (2017)
108. Rodgers RJ, "Complex diseases and co-morbidities : polycystic ovary syndrome and type 2 diabetes mellitus", Endocr Connect, 8, pp.R71~5 (2019)
109. Zore T, "Polycystic ovarian syndrome : long-term health consequences", Semin Reprod Med, 35, pp.271~281 (2017)
110. Wu J, "A potential link between polycystic ovary syndrome and non-alcoholic fatty liver disease : an update meta-analysis", Reprod Health, 15, pp.77~ (2018)
111. Esmaeilinezhad Z, "Effect of synbiotic pomegranate juice on glycemic, sex hormone profile and anthropometric indices in PCOS : a randomized, triple blind, controlled trial", Nutr Metab Cardiovasc Dis, 29, pp.201~208 (2019)
112. Darvishi S, "Synbiotic supplementation improves metabolic factors and obesity values in women with polycystic ovary syndrome independent of affecting apelin levels : a randomized double-blind placebo-controlled clinical trial", Int J Fertil Steril, 15, pp.51~59 (2021)
113. Karimi E, "Effects of synbiotic supplementation on metabolic parameters and apelin in women with polycystic ovary syndrome : a randomised double-blind placebo-controlled trial", Br J Nutr, 119, pp.398~406 (2018)

관련 논문AI추천